Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840
Clinical trial NCT04422431 · COMPLETED
Trial details
- NCT number
- NCT04422431
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2022-05-21
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.